Bacterial diarrhoea
KL Kotloff - Current opinion in pediatrics, 2022 - journals.lww.com
Management of bacterial diarrhoea includes standard fluid and electrolyte therapy, vigilance
for potential complications, and use of antibiotics for children who have moderate-severe …
for potential complications, and use of antibiotics for children who have moderate-severe …
Why antibiotics should not be used to treat Shiga toxin-producing Escherichia coli infections
PI Tarr, SB Freedman - Current opinion in gastroenterology, 2022 - journals.lww.com
In high-income countries, antibiotics should not routinely be given to patients with acute
diarrhea unless testing demonstrates a pathogen for which antibiotics are indicated, and …
diarrhea unless testing demonstrates a pathogen for which antibiotics are indicated, and …
AB5 Enterotoxin-Mediated Pathogenesis: Perspectives Gleaned from Shiga Toxins
EN Biernbaum, IT Kudva - Toxins, 2022 - mdpi.com
Foodborne diseases affect an estimated 600 million people worldwide annually, with the
majority of these illnesses caused by Norovirus, Vibrio, Listeria, Campylobacter, Salmonella …
majority of these illnesses caused by Norovirus, Vibrio, Listeria, Campylobacter, Salmonella …
Enterohemorrhagic Escherichia coli and a Fresh View on Shiga Toxin-Binding Glycosphingolipids of Primary Human Kidney and Colon Epithelial Cells and Their …
J Detzner, G Pohlentz, J Müthing - International Journal of Molecular …, 2022 - mdpi.com
Enterohemorrhagic Escherichia coli (EHEC) are the human pathogenic subset of Shiga
toxin (Stx)-producing E. coli (STEC). EHEC are responsible for severe colon infections …
toxin (Stx)-producing E. coli (STEC). EHEC are responsible for severe colon infections …
Interventions for Shiga toxin-producing Escherichia coli gastroenteritis and risk of hemolytic uremic syndrome: A population-based matched case control study
S Myojin, K Pak, M Sako, T Kobayashi, T Takahashi… - Plos one, 2022 - journals.plos.org
Background The role of antibiotics in the treatment of Shiga toxin-producing Escherichia coli
(STEC) infection is controversial. Objectives To evaluate the association between treatment …
(STEC) infection is controversial. Objectives To evaluate the association between treatment …
Shiga toxin (Stx) type 2‐induced increase in O‐linked N‐acetyl glucosamine protein modification: a new therapeutic target?
RA Bova, A Melton‐Celsa - EMBO Molecular Medicine, 2022 - embopress.org
Shiga toxin (Stx)‐producing Escherichia coli (STEC) causes bloody diarrhea, which may
progress to the potentially fatal hemolytic uremic syndrome (HUS). Development of HUS …
progress to the potentially fatal hemolytic uremic syndrome (HUS). Development of HUS …
[PDF][PDF] Influencia de la infección bacteriana y los monosacáridos derivados del mucus intestinal sobre la virulencia de E. coli productor de toxina Shiga. Evaluación de …
NE Garimano - 2022 - bibliotecadigital.exactas.uba.ar
Escherichia coli productora de toxina Shiga (STEC) es un patógeno transmitido por
alimentos, responsable de causar el Síndrome urémico hemolítico (SUH) en humanos a …
alimentos, responsable de causar el Síndrome urémico hemolítico (SUH) en humanos a …